Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

Market open

 --Real time quotes

May 19, 2022, 1:58 p.m.

/zigman2/quotes/207301221/composite

$

0.58

Change

+0.02 +3.52%

Volume

Volume 64,408

Real time quotes

/zigman2/quotes/207301221/composite

Previous close

$ 0.56

$ 0.58

Change

+0.02 +3.52%

Day low

Day high

$0.56

$0.59

Open

52 week low

52 week high

$0.50

$4.86

Open

William I. Huyett

Transactions

Date Shares Transaction Value
11/06/2020 3,827   Disposition at $2.52 per share. 9,645
02/21/2020 3,559   Disposition at $5.12 per share. 18,223
11/08/2019 3,922   Disposition at $2.05 per share. 8,041
04/01/2019 39,172   Award at $0 per share. 0
04/01/2019 39,179   Award at $0 per share. 0
04/01/2019 38,320   Award at $0 per share. 0
04/01/2019 38,327   Award at $0 per share. 0

Officers and Executives

Dr. Peter M. Hecht
Chief Executive Officer & Director
Ms. Cheryl Gault
Chief Operating Officer
Ms. Anjeza Gjino
Chief Financial Officer
Mr. Kevin Durfee
Vice President-Information Technology & Facilities
Dr. Andreas Eugen Busch
Chief Scientific Officer
Dr. G. Todd Milne
Senior Vice President-Corporate Development
Dr. Jennifer Chickering
Vice President-Clinical Strategy
Ms. Marsha H. Fanucci
Chairman
Dr. Errol B. de Souza
Independent Director
Ms. Stephanie Lovell
Independent Director
Dr. Michael E. Mendelsohn
Independent Director
Dr. Ole Isacson
Independent Director
Mr. Terrance G. McGuire
Independent Director
Mr. George H. Conrades
Independent Director
Link to MarketWatch's Slice.